Holopack Verpackungstechnik GmbH (secondary packaging, control; manufacturing of unpackaged products, primary and secondary packaging, control)
UkraineAll drugs from this manufacturer
-
The drug is used to treat complications caused by impaired detoxification function of the liver (e.g., in cirrhosis), especially if there are symptoms of hepatic encephalopathy, including impaired consciousness (precoma, coma).
Dosage form: concentrate for infusion solution
Active substance Dosage l-ornithine-l-aspartate 500 mg/ml ATC: A05BA